MolNFT v1 · #13324 · protein
Crystal structure of CA2+/CALMODULIN complexed with myristoylated cap-23/NAP-22 peptide
1L7Z: “Crystal structure of CA2+/CALMODULIN complexed with myristoylated cap-23/NAP-22 peptide”. X-ray diffraction, 2 ligands (MYR, CA), 1 pocket (best druggability 0.79). MolNFT v1 #13324 on GenesisL1: 3D structure, binding sites and…
- PDB
- 1L7Z
- Type
- protein
- Length
- 148 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Calmodulin; Cap-23/NAP-22
- UniProt
- P62158
- Ligands
- MYR, CA
- Pockets
- 1 · best druggability 0.79
Structure
x-ray diffraction · 2 distinct chains · 53% helix, 5% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Calmodulin | protein | 142 | 55% helix, 6% strand | P62158 |
| B | Cap-23/NAP-22 | protein | 6 | 0% helix, 0% strand | — |
Ligands and binding sites
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1005 | 0.79 | 0.80 | 58 | MYR |
Interfaces
1 interface between chains.
- A–B · 392 Ų buried · 2 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 1 lipid (myristoylation).
Compared structures
- 1L7Z · Crystal structure of Ca2+/Calmodulin complexed with myristoylated CAP-23/NAP-22 peptide · the same entry in another collection · chain B against B, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P62158
- Elsewhere: RCSB PDB 1L7Z · PDBe 1L7Z · UniProt P62158
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.